US0327241065
US0327241065
AnaptysBio, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 234.603.000 | 91.280.000 | 157.0% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 7.701.000 | 25.128.000 | 69.4% | |
| Operating Income | 226.902.000 | 66.152.000 | 243.0% |
| Pretax Income | 162.275.000 | 31.139.000 | 421.1% |
| Net Income Common Stockholders | -13.232.000 | -145.231.000 | 90.9% |
| -- | -- | -- | |
| -- | -- | -- |